cardene iv

Generic: nicardipine hydrochloride

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name cardene iv
Generic Name nicardipine hydrochloride
Labeler baxter healthcare corporation
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

nicardipine hydrochloride .1 mg/mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 43066-009
Product ID 43066-009_af59ed9a-2f67-4aa6-8065-42cc661a4784
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA019734
Listing Expiration 2026-12-31
Marketing Start 1992-01-30

Pharmacologic Class

Classes
calcium channel antagonists [moa] cytochrome p450 2c19 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43066009
Hyphenated Format 43066-009

Supplemental Identifiers

RxCUI
858599 858601 858603 858605
UNII
K5BC5011K3

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cardene iv (source: ndc)
Generic Name nicardipine hydrochloride (source: ndc)
Application Number NDA019734 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .1 mg/mL
source: ndc
Packaging
  • 10 BAG in 1 CARTON (43066-009-10) / 200 mL in 1 BAG
source: ndc

Packages (1)

Ingredients (1)

nicardipine hydrochloride (.1 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "af59ed9a-2f67-4aa6-8065-42cc661a4784", "openfda": {"unii": ["K5BC5011K3"], "rxcui": ["858599", "858601", "858603", "858605"], "spl_set_id": ["f12cea0d-b7cd-41d8-b551-2c74cc7f5f4e"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 CARTON (43066-009-10)  / 200 mL in 1 BAG", "package_ndc": "43066-009-10", "marketing_start_date": "20210111"}], "brand_name": "CARDENE IV", "product_id": "43066-009_af59ed9a-2f67-4aa6-8065-42cc661a4784", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "43066-009", "generic_name": "nicardipine hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CARDENE IV", "active_ingredients": [{"name": "NICARDIPINE HYDROCHLORIDE", "strength": ".1 mg/mL"}], "application_number": "NDA019734", "marketing_category": "NDA", "marketing_start_date": "19920130", "listing_expiration_date": "20261231"}